As cases of intussusception reported from other hospitals could not be confirmed using the Brighton Collaboration Case Definition, they were not included in the calculation of incidence and therefore the incidence rate from sentinel site surveillance reflects the hospital incidence rate rather than HSP inhibitor review the population incidence and therefore may under

estimate the true population based intussusception incidence. However, it is possible to estimate population based incidence rates based on results from a sentinel site study if data of admissions from other hospitals in the region is accessible and accurate, cases can be verified, and if there is a clear understanding of regional population migration and health seeking behaviour. Based on the data obtained in this study, we estimated an incidence rate of intussusception in infants 0–24 months of 3.48 per 10,000 infants (0–24 months) in the State of Victoria. This is consistent with previously published incidence rates for Victorian infants Enzalutamide cost (3.8 per 10,000 infants in 1994–2000) [24]. The completeness and accuracy of data describing the clinical presentation and management of intussusception is highly dependent on the quality of the description of symptoms and signs recorded in medical records. The specificity of case

ascertainment was high in the present study, therefore we believe clinical data are accurate reflection of intussusception patients admitted to Royal Children’s Hospital over the study period. The data captured on the range of clinical presentation, diagnosis methods and outcomes were similar to that reported in previous retrospective studies conducted at Royal Children’s Hospital that includes data collected over a 40-year period [12] and [25]. Intussusception is rare in infants <2 months of age and there has not been a case in this age group reported in this study or in the previous cohort extending back to 1994 [11]. The clinical presentation is consistent

with that observed in previous studies. The proportion of infants requiring surgery was higher in the younger (≤6 months) compared to older infants (>6 months of age). In the present study we observed ALOX15 a lower rate of intestinal resection (6.5%: 95% CI 3.6%, 11.0%) than that reported in the earlier study (11.5%) [11]. In the present study we accessed the Australian Childhood Immunisation Register to assess the accuracy of immunisation data recorded in the hospital medical record and verify the vaccination status of children hospitalised for intussusception at the Royal Children’s Hospital. Recognising that this study collected data on both before and after introduction of a rotavirus vaccine into the National Immunisation Program we have limited data on the impact of hospitalisations following administration of a rotavirus vaccine.